L Mikiashvili
Overview
Explore the profile of L Mikiashvili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mikiashvili L, Kempker R, Chakhaia T, Bablishvili N, Avaliani Z, Lomtadze N, et al.
Clin Infect Dis
. 2023 Nov;
78(4):1043-1052.
PMID: 37962987
Background: There are scarce data on the clinical outcomes of persons retreated with new/companion anti-tuberculosis (TB) drugs for multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). We sought to evaluate the efficacy and...
2.
Graciaa D, Kempker R, Sanikidze E, Tukvadze S, Mikiashvili L, Aspindzelashvili R, et al.
Int J Tuberc Lung Dis
. 2021 Mar;
25(3):167-170.
PMID: 33688804
No abstract available.
3.
Mikiashvili L, Kipiani M, Schechter M, Avaliani Z, Kiria N, Kempker R
Int J Tuberc Lung Dis
. 2020 Apr;
24(4):436-443.
PMID: 32317069
Data on the long-term use of linezolid (LZD) in the treatment of drug-resistant pulmonary tuberculosis (DR-PTB) are limited. To assess safety, tolerability and efficacy of LZD-containing regimens for the treatment...
4.
Kempker R, Mikiashvili L, Zhao Y, Benkeser D, Barbakadze K, Bablishvili N, et al.
Clin Infect Dis
. 2019 Nov;
71(9):2336-2344.
PMID: 31712809
Background: Bedaquiline and delamanid are newly available drugs for treating multidrug-resistant tuberculosis (MDR-TB); however, there are limited data guiding their use and no comparison studies. Methods: We conducted a prospective,...